EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours-Reference-Cited by-同舟云学术

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

Published:2017-07 Issue: Volume:28 Page:iv84-iv99
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Le Rhun E.,Weller M.,Brandsma D.,Van den Bent M.,de Azambuja E.,Henriksson R.,Boulanger T.,Peters S.,Watts C.,Wick W.,Wesseling P.,Rudà R.,Preusser M.

Funder

ESMO

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/suppl_4/iv84/18564046/mdx221.pdf

Reference147 articles.

1. Leptomeningeal metastases: a RANO proposal for response criteria;Chamberlain;Neuro Oncol,2017

2. Breast cancer leptomeningeal metastasis—the role of multimodality treatment;Rudnicka;J Neurooncol,2007

3. Survival of breast cancer patients with meningeal carcinomatosis;Gauthier;Ann Oncol,2010

4. Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations;Lee;Breast Cancer Res Treat,2011

5. Meningeal carcinomatosis in breast cancer: prognostic factors and outcome;de Azevedo;J Neurooncol,2011

Cited by 306 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Leptomeningeal Metastases from Breast Cancer: A Literature Review;Journal of Medical Clinical Case Reports;2024-12-15

2. A Comprehensive Review of Current Treatment Modalities for Leptomeningeal Carcinomatosis in Breast Cancer;Critical Reviews in Oncology/Hematology;2024-09

3. Small-cell neuroendocrine carcinoma of the cervix with leptomeningeal spread: A rare coincidence report and literature review;Surgical Neurology International;2024-08-30

4. Tyrosine kinase inhibitors in the treatment of leptomeningeal carcinomatosis;Cell Biology International;2024-08-13

5. Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy;Journal of Clinical Oncology;2024-08-10